291 related articles for article (PubMed ID: 19926713)
1. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
[TBL] [Abstract][Full Text] [Related]
2. Adult Height of Patients with SHOX Haploinsufficiency with or without GH Therapy: A Real-World Single-Center Study.
Dantas NCB; Funari MFA; Vasques GA; Andrade NLM; Rezende RC; Brito V; Scalco RC; Arnhold IJP; Mendonca BB; Jorge AAL
Horm Res Paediatr; 2022; 95(3):264-274. PubMed ID: 35390795
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.
Ogata T; Onigata K; Hotsubo T; Matsuo N; Rappold G
Endocr J; 2001 Jun; 48(3):317-22. PubMed ID: 11523902
[TBL] [Abstract][Full Text] [Related]
4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
5. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
[TBL] [Abstract][Full Text] [Related]
6. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
[TBL] [Abstract][Full Text] [Related]
7. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
[TBL] [Abstract][Full Text] [Related]
8. GH and GnRH analog treatment in children who enter puberty at short stature.
Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
[TBL] [Abstract][Full Text] [Related]
9. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
Wit JM
Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
[TBL] [Abstract][Full Text] [Related]
10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
van der Steen M; Lem AJ; van der Kaay DC; Bakker-van Waarde WM; van der Hulst FJ; Neijens FS; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
[TBL] [Abstract][Full Text] [Related]
12. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
14. Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto's thyroiditis.
Quintos JB; Salas M
J Pediatr Endocrinol Metab; 2005 May; 18(5):515-21. PubMed ID: 15921183
[TBL] [Abstract][Full Text] [Related]
15. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.
Binder G; Schwarze CP; Ranke MB
J Clin Endocrinol Metab; 2000 Jan; 85(1):245-9. PubMed ID: 10634394
[TBL] [Abstract][Full Text] [Related]
16. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
[TBL] [Abstract][Full Text] [Related]
18. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity.
Binder G; Renz A; Martinez A; Keselman A; Hesse V; Riedl SW; Häusler G; Fricke-Otto S; Frisch H; Heinrich JJ; Ranke MB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4403-8. PubMed ID: 15356038
[TBL] [Abstract][Full Text] [Related]
19. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
